🟢 Tscan Therapeutics is trading 5% up

Tscan Therapeutics is trading at $0.22, up 5.04%, with no clear company-specific announcement identified to explain the October 20 move.

• A filing for the November 20 shareholder meeting proposes a reverse split, but it predates the move and does not establish its cause.
• The supplied sector context reports biotech rising 2.09%, a possible industry tailwind; available evidence does not confirm it drove the stock’s gain.